Perioperative allogeneic nonleukoreduced blood transfusion and prostate cancer outcomes after radical prostatectomy

Transfusion

Volumn 54, Issue 9, 2014, Pages 2175-2181

  Yeoh, Tze Yeng ^a,b   Scavonetto, Federica ^a   Weingarten, Toby N ^a   Karnes, R Jeffrey ^a   Van Buskirk, Camille M ^a   Hanson, Andrew C ^a   Schroeder, Darrell R ^a   Sprung, Juraj ^a  

^a MAYO CLINIC   (United States)

^b NATIONAL UNIVERSITY HOSPITAL   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

AGED; ALLOGENEIC NONLEUKOREDUCED BLOOD TRANSFUSION; ARTICLE; BLOOD TRANSFUSION; CANCER MORTALITY; CANCER PROGNOSIS; CANCER SURVIVAL; CONTROLLED STUDY; GLEASON SCORE; HUMAN; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; PERIOPERATIVE PERIOD; PROSTATE CANCER; PROSTATECTOMY; RADICAL RETROPUBIC PROSTATECTOMY; RISK ASSESSMENT; TUMOR GROWTH; MIDDLE AGED; PATHOLOGY; PROCEDURES; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDY; TUMOR RECURRENCE;

AGED; BLOOD TRANSFUSION; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84908214510     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.12595     Document Type: Article

References (27)

1. Gould S, Cimino MJ, Gerber DR. Packed red blood cell transfusion in the intensive care unit: limitations and consequences. Am J Crit Care 2007;16:39-48.
2. Madjdpour C, Spahn DR. Allogeneic red blood cell transfusions: efficacy, risks, alternatives and indications. Br J Anaesth 2005;95:33-42.
3. Buddeberg F, Schimmer BB, Spahn DR. Transfusiontransmissible infections and transfusion-related immunomodulation. Best Pract Res Clin Anaesthesiol 2008;22:503-17.
4. Vamvakas EC, Blajchman MA. Transfusion-related immunomodulation (TRIM): an update. Blood Rev 2007; 21:327-48.
5. Gantt CL. Red blood cells for cancer patients. Lancet 1981; 2:363.
6. Busch OR, Hop WC, Marquet RL, et al. Blood transfusions and local tumor recurrence in colorectal cancer. Evidence of a noncausal relationship. Ann Surg 1994;220:791-7.
7. Eickhoff JH, Andersen J, Laybourn C. Perioperative blood transfusion does not promote recurrence and death after mastectomy for breast cancer. The Danish Breast Cancer Cooperative Group. Br J Surg 1991;78:1358-61.
8. Linder BJ, Frank I, Cheville JC, et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur Urol 2013;63: 839-45.
9. Pena CM, Rice TW, Ahmad M, et al. Significance of perioperative blood transfusions in patients undergoing resection of stage I and II non-small-cell lung cancers. Chest 1992;102:84-8.
10. Acheson AG, Brookes MJ, Spahn DR. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann Surg 2012;256:235-44.
11. Gallina A, Briganti A, Chun FK, et al. Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy. BJU Int 2007;100:1249-53.
12. Ness PM, Walsh PC, Zahurak M, et al. Prostate cancer recurrence in radical surgery patients receiving autologous or homologous blood. Transfusion (Paris) 1992;32:31-6.
13. Paul R, Schmid R, Busch R, et al. Influence of blood transfusions during radical retropubic prostatectomy on disease outcome. Urology 2006;67:137-41.
14. Ford BS, Sharma S, Rezaishiraz H, et al. Effect of perioperative blood transfusion on prostate cancer recurrence. Urol Oncol 2008;26:364-7.
15. Velagapudi SR, Frydenberg M, Oesterling JE, et al. Homologous blood transfusion in patients with prostate cancer: no effect on tumor progression or survival. Urology 1994;43: 821-7.
16. Davies AH, Ramarakha P, Cranston D, et al. Effect of blood transfusion on survival after radiotherapy as treatment for carcinoma of the prostate. Ann R Coll Surg Engl 1991;73: 116-8.
17. Heal JM, Chuang C, Blumberg N. Perioperative blood transfusions and prostate cancer recurrence and survival. Am J Surg 1988;156:374-80.
18. McClinton S, Moffat LE, Scott S, et al. Blood transfusion and survival following surgery for prostatic carcinoma. Br J Surg 1990;77:140-2.
19. Bar-Yosef S, Melamed R, Page GG, et al. Attenuation of the tumor-promoting effect of surgery by spinal blockade in rats. Anesthesiology 2001;94:1066-73.
20. Snyder GL, Greenberg S. Effect of anaesthetic technique and other perioperative factors on cancer recurrence. Br J Anaesth 2010;105:106-15.
21. Scavonetto F, Yeoh TY, Umbreit EC, et al. The association between neuraxial analgesia and cancer progression and mortality after radical prostatectomy: a retrospective matched cohort study. Br J Anaesth 2013 Dec. 16. [Epub ahead of print; doi: 10.1093/bja/aet467].
22. Rosenbaum PR. Optimal matching for observational studies. JASA 1989;84:1024-32.
23. Hosking MP, Warner MA, Lobdell CM, et al. Outcomes of surgery in patients 90 years of age and older. JAMA 1989; 261:1909-15.
24. American Pain Society. Principles of analgesic use in the treatment of acute pain and cancer pain. 4th ed. Skokie (IL): American Pain Society; 1999.
25. Fleming, ID, Cooper JS, Henson DE, et al., editors. AJCC cancer staging manual. 5th ed. Philadelphia, New York: Lippincott-Raven; 1997.
26. Yeager MP, Rosenkranz KM. Cancer recurrence after surgery: A role for regional anesthesia? Reg Anesth Pain Med 2010;35:483-4
27. Oefelein MG, Colangelo LA, Rademaker AW, et al. Intraoperative blood loss and prognosis in prostate cancer patients undergoing radical retropubic prostatectomy. J Urol 1995;154:442-7.